Market Cap

Shenzhen Bioeasy Biotechnology Co. Ltd Market Capitalization:

CN¥4.59 Billion

CNY as of Jan. 1, 2024

US$646.2 Million

business Shenzhen Bioeasy Biotechnology Co. Ltd Company Profile

Shenzhen Bioeasy Biotechnology Co. Ltd Main Stock Listing

SZSE: 300942

Market Capitalization History of Shenzhen Bioeasy Biotechnology Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Shenzhen Bioeasy Biotechnology Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥4.59 B -33.64%
Jan. 1, 2023 CN¥6.92 B -38.88%
Jan. 1, 2022 CN¥11.32 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Shenzhen Bioeasy Biotechnology Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Shenzhen Bioeasy Biotechnology Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300942

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.